In addition, genetics might also contribute to drug-specific toxic effects as a previous study demonstrated that dihydropyrimidine dehydrogenase (DPYD) deficiency was associated with reduced clearance of and prolonged exposure to fluoropyrimidines. Here, DPYD is linked to hyperinsulinemic hypoglycemia, familial, 4.